Skip to main content

Compare Stocks

Date Range: 

 NTN BuzztimeQ BioMedMateon TherapeuticsInMed PharmaceuticalsMidatech Pharma
SymbolNYSEAMERICAN:NTNOTCMKTS:QBIOOTCMKTS:MATNNASDAQ:INMNASDAQ:MTP
Price Information
Current Price$30.60$1.05$0.30$3.38$2.07
52 Week RangeN/AN/ABuyBuyN/A
MarketRank™
Overall Score0.40.51.51.70.7
Analysis Score0.00.03.53.50.0
Community Score2.02.62.65.03.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.80.00.0
Earnings & Valuation Score0.00.00.60.00.6
Analyst Ratings
Consensus RecommendationN/AN/ABuyBuyN/A
Consensus Price TargetN/AN/A$3.00$11.50N/A
% Upside from Price TargetN/AN/A916.95% upside240.24% upsideN/A
Trade Information
Market Cap$91.10 million$27.43 million$26.62 million$27.21 million$26.24 million
Beta0.722.11.52N/A2.63
Average Volume1,629,816105,523338,444186,137692,796
Sales & Book Value
Annual Revenue$19.81 millionN/AN/AN/A$860,000.00
Price / Sales4.60N/AN/AN/A30.51
Cashflow$6.99 per shareN/AN/AN/AN/A
Price / Cash4.38N/AN/AN/AN/A
Book Value$1.76 per share($0.26) per share$0.20 per shareN/A$40.82 per share
Price / Book17.39N/AN/AN/A0.05
Profitability
Net Income$-2,050,000.00$-10,280,000.00$-6,640,000.00N/A$-12,880,000.00
EPSN/AN/AN/AN/AN/A
Trailing P/E RatioN/AN/A0.000.000.00
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-61.42%N/AN/AN/AN/A
Return on Equity (ROE)-162.54%N/A-64.66%N/AN/A
Return on Assets (ROA)-49.94%-678.41%-42.92%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio3.30%N/AN/AN/A0.02%
Current Ratio0.95%0.88%0.17%N/A1.40%
Quick Ratio0.95%0.88%0.17%N/AN/A
Ownership Information
Institutional Ownership Percentage6.31%0.04%0.04%N/A2.27%
Insider Ownership Percentage24.20%N/A39.22%N/AN/A
Miscellaneous
Employees19413N/A65
Shares Outstanding2.98 million26.12 million90.24 million8.05 million12.68 million
Next Earnings Date5/18/2021 (Estimated)7/21/2021 (Estimated)N/A5/13/2021 (Confirmed)6/21/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Midatech Pharma plc (NASDAQ:MTP) Sees Large Decline in Short InterestMidatech Pharma plc (NASDAQ:MTP) Sees Large Decline in Short Interest
americanbankingnews.com - May 4 at 4:22 PM
Midatech Pharma PLC - MTX110 Update & Headline Results for 2020Midatech Pharma PLC - MTX110 Update & Headline Results for 2020
proactiveinvestors.co.uk - March 25 at 8:59 AM
Midatech Pharma PLC Announces MTX110 Update & Headline Results for 2020Midatech Pharma PLC Announces MTX110 Update & Headline Results for 2020
finance.yahoo.com - March 25 at 3:59 AM
Is Midatech Pharma plc(NASDAQ:MTP) Stock Good For Long-Term Investing?Is Midatech Pharma plc(NASDAQ:MTP) Stock Good For Long-Term Investing?
stocksregister.com - February 11 at 10:53 PM
Midatech Pharma plc [MTP] is 65.78% higher this YTD. Is it still time to buy?Midatech Pharma plc [MTP] is 65.78% higher this YTD. Is it still time to buy?
dbtnews.com - February 10 at 7:57 PM
Midatech Pharma plc (MTP): What is good about stock?Midatech Pharma plc (MTP): What is good about stock?
marketingsentinel.com - February 10 at 7:57 PM
Selling your Midatech Pharma plc (NASDAQ:MTP) stock? Here’s what you need to knowSelling your Midatech Pharma plc (NASDAQ:MTP) stock? Here’s what you need to know
stocksregister.com - February 6 at 6:00 PM
Midatech Pharma plc [MTP] is 37.97% higher this YTD. Is it still time to buy?Midatech Pharma plc [MTP] is 37.97% higher this YTD. Is it still time to buy?
dbtnews.com - February 6 at 6:00 PM
Midatech Pharma plc (NASDAQ:MTP) Contineus To Thrive In 2021, As Its Stock Is Up 37.97% Year-To-DateMidatech Pharma plc (NASDAQ:MTP) Contineus To Thrive In 2021, As Its Stock Is Up 37.97% Year-To-Date
marketingsentinel.com - February 5 at 10:56 PM
Midatech Pharma PLC Announces Business UpdateMidatech Pharma PLC Announces Business Update
marketwatch.com - January 26 at 8:29 AM
Midatech Pharma PLC - Launch of new websiteMidatech Pharma PLC - Launch of new website
proactiveinvestors.co.uk - December 11 at 10:25 PM
Midatech Pharma PLC Announces Launch of new websiteMidatech Pharma PLC Announces Launch of new website
finance.yahoo.com - December 11 at 7:21 AM
Midatechs MTX110 shows encouraging action in early stage of fatal childhood brain cancer, shares up 37%Midatech's MTX110 shows encouraging action in early stage of fatal childhood brain cancer, shares up 37%
seekingalpha.com - October 19 at 8:41 AM
Midatechs MTX110 shows survival benefit in rare pediatric brain cancer study, shares up 37%Midatech's MTX110 shows survival benefit in rare pediatric brain cancer study, shares up 37%
seekingalpha.com - October 19 at 8:41 AM
Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG StudyMidatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study
apnews.com - October 19 at 3:40 AM
Midatech Pharma plc (MTP) CEO Stephen Stamp on Q2 2020 Results - Earnings Call TranscriptMidatech Pharma plc (MTP) CEO Stephen Stamp on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - September 10 at 11:14 PM
Midatech Pharma plc (MTP) CEO Craig Cook on Q2 2020 Results - Earnings Call TranscriptMidatech Pharma plc (MTP) CEO Craig Cook on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - September 10 at 12:49 PM
Midatech Pharma PLC Announces Interim results - 6 months ended 30 June 2020Midatech Pharma PLC Announces Interim results - 6 months ended 30 June 2020
finance.yahoo.com - September 10 at 2:31 AM
Midatech Pharma PLC Announces Investor WebinarMidatech Pharma PLC Announces Investor Webinar
finance.yahoo.com - September 7 at 7:10 AM
BNTX, BKE among premarket gainersBNTX, BKE among premarket gainers
seekingalpha.com - August 21 at 8:56 AM
Midatech rallies 49% but news scarceMidatech rallies 49% but news scarce
seekingalpha.com - August 21 at 8:56 AM
Midatech Pharma PLC Announces Exercise of Warrants and Issue of EquityMidatech Pharma PLC Announces Exercise of Warrants and Issue of Equity
finance.yahoo.com - August 19 at 3:37 AM
Stock Alert: Midatech Pharma Shares Up 80%Stock Alert: Midatech Pharma Shares Up 80%
nasdaq.com - August 14 at 1:11 PM
Midatech Pharma PLC Announces Registration Statement Declared EffectiveMidatech Pharma PLC Announces Registration Statement Declared Effective
finance.yahoo.com - August 14 at 7:44 AM
Midatech Pharma PLC ADR MTPMidatech Pharma PLC ADR MTP
morningstar.com - August 12 at 11:35 PM
DateCompanyBrokerageAction
5/10/2019Q BioMedBrookline Capital ManagementReiterated Rating
11/29/2018Q BioMedRoth CapitalDowngrade
12/7/2020Mateon TherapeuticsLitchfield Hills ResearchInitiated Coverage
4/22/2019Mateon TherapeuticsHC WainwrightReiterated Rating
(Data available from 5/13/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.